Spectral AI Inc
NASDAQ:MDAI
Spectral AI Inc
Spectral AI Inc is a US-based company operating in industry. The company is headquartered in Dallas, Texas. The company went IPO on 2021-02-12. Rosecliff Acquisition Corp I is a blank check company. The firm is formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination. The firm has not selected any specific business combination target. The firm intends to focus its search on identifying high growth technology and tech-enabled businesses.
Spectral AI Inc is a US-based company operating in industry. The company is headquartered in Dallas, Texas. The company went IPO on 2021-02-12. Rosecliff Acquisition Corp I is a blank check company. The firm is formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination. The firm has not selected any specific business combination target. The firm intends to focus its search on identifying high growth technology and tech-enabled businesses.
Revenue Drop: Q3 2025 research and development revenue fell to $3.8 million from $8.2 million last year due to reduced BARDA contract reimbursements post-FDA submission.
Guidance Lowered: Full-year 2025 revenue guidance was cut from $21.5 million to $18.5 million, reflecting reduced BARDA work and government shutdown timing.
Larger Net Loss: Net loss increased to $3.6 million in Q3 2025 from $1.5 million a year ago, mainly due to lower revenue and higher administrative expenses.
Strong Cash Position: Cash and equivalents at September 30, 2025, totaled $10.5 million, not including $7.6 million raised in October.
FDA Process On Track: Management reports continued progress and strong communication with the FDA, with no major roadblocks to anticipated first-half 2026 approval.
Positive User Feedback: Feedback on international DeepView placements has been highly positive, informing improvements for the planned U.S. launch.
Handheld Development: Military-funded handheld device development is advancing and considered complementary to the main cart-based system.
